“Impurity in the raw material”, AIFA withdraws some hypertension drug batches from pharmacies

Alert from the Swiss Medicines Agency

(by Giovanni D'Agata) Another health alert: after antifungal, antidepressant, blood products and eye drops withdrawn a few days ago, Aifa has just removed three batches of another drug from the Italian market in a few hours. These are lots no. VALSARTAN ID TE * 28CPR80 + 12,5MG - AIC 040259069 - lot n. 0006204 expiry 31-12-2020 and • VALSARTAN TEVA * 14CPR RIV 40MG - AIC 040149039 - lots n. W31046 exp. 29-02-2020 and n. W31048 exp. 30-04-2020.

The measure, underlines Giovanni D'Agata, president of the “Rights Desk”, was necessary following the alert notification from the Swiss medicines agency concerning the presence of impurities deriving from the production process of the raw material.

Valsartan Hydrochloritazide Teva is used in the treatment of essential hypertension in adults. The Carabinieri Command for the Protection of Health is invited to verify the withdrawal, and in case of non-fulfillment by the Teva Italia company, it will proceed with the seizure of the batches of the medicine.

“Impurity in the raw material”, AIFA withdraws some hypertension drug batches from pharmacies

| NEWS ' |